Lee, Jeong Hee; In, Youngyong; Lee, Il-hyung; Lee, Joon Woo - In: Journal of Open Innovation: Technology, Market, and … 2 (2016) 1, pp. 1-25
-front payment (up-front fee + milestones), regarding drug candidates for specific drug classes, like anticancer or cardiovascular … corresponding development phase of the drug candidate for the license deal and the revenue data of the license buyer (licensee … investigated. Findings: For the anticancer (antineoplastics) and cardiovascular drug classes, the formula to predict the royalty …